Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 3546 entries
View as:

Market Potential of Carbon Dioxide Nasal Spray

Phase: N/A Priority: Normal
NCT ID: NCT02113449 Org: User:
Start: 11/30/13 End: 02/28/14 Due: 02/28/15

Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

Phase: N/A Priority: Normal
NCT ID: NCT00614614 Org: User:
Start: 02/13/08 End: 09/17/09 Due: 09/17/10

Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States

Phase: N/A Priority: Normal
NCT ID: NCT02019732 Org: User:
Start: 01/31/13 End: 06/30/13 Due: 06/30/14

A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06188507 Org: User:
Start: 01/12/24 End: 03/19/26 Due: 03/19/27

Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00808093 Org: User:
Start: 05/12/08 End: 08/27/08 Due: 08/27/09

15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00495729 Org: User:
Start: 04/18/07 End: 08/04/07 Due: 08/04/08

Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives

Phase: N/A Priority: Normal
NCT ID: NCT00508365 Org: User:
Start: 09/25/07 End: 06/03/08 Due: 06/03/09

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02465515 Org: User:
Start: 07/01/15 End: 03/14/18 Due: 03/14/19

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

Phase: N/A Priority: Normal
NCT ID: NCT00727428 Org: User:
Start: 08/05/08 End: 02/17/09 Due: 02/17/10

Brain Metastases In ErbB2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00437073 Org: User:
Start: 05/31/07 End: 02/28/10 Due: 02/28/11

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

Phase: N/A Priority: Normal
NCT ID: NCT00317122 Org: User:
Start: 10/31/04 End: 07/31/05 Due: 07/31/06

The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT02064465 Org: User:
Start: 03/15/14 End: 07/08/14 Due: 07/08/15

A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT01440387 Org: User:
Start: 09/30/11 End: 10/22/11 Due: 10/22/12

Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT05677347 Org: User:
Start: 01/23/23 End: 07/20/23 Due: 07/20/24

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT02360475 Org: User:
Start: 03/20/15 End: 06/21/16 Due: 06/21/17

Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00699231 Org: User:
Start: 02/29/92 End: 12/31/92 Due: 12/31/93

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Phase: N/A Priority: Normal
NCT ID: NCT00148928 Org: User:
Start: 03/01/05 End: 11/07/06 Due: 11/07/07

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT03276962 Org: User:
Start: 09/28/17 End: 11/14/22 Due: 11/14/23

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Phase: N/A Priority: Normal
NCT ID: NCT00297206 Org: User:
Start: 01/25/03 End: 02/28/07 Due: 02/28/08

SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)

Phase: N/A Priority: Normal
NCT ID: NCT01636271 Org: User:
Start: 10/31/11 End: 04/30/14 Due: 04/30/15

Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02630251 Org: User:
Start: 04/25/16 End: 12/13/18 Due: 12/13/19

Drug Use Investigation for LAMICTAL

Phase: N/A Priority: Normal
NCT ID: NCT01376180 Org: User:
Start: 12/31/08 End: 08/31/16 Due: 08/31/17

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT06680375 Org: User:
Start: 11/11/24 End: 06/05/25 Due: 06/05/26

Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06201559 Org: User:
Start: 08/21/23 End: 09/12/23 Due: 09/12/24

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

Phase: N/A Priority: Normal
NCT ID: NCT00356603 Org: User:
Start: 06/20/06 End: 08/07/06 Due: 08/07/07